## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `article_bundle` — **LLM article bundle**
Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.
- **article slug:** `kpv`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system.
- **read:** https://miscsubjects.com/api/articles/kpv/bundle?format=markdown

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/kpv/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/kpv/topology
- **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/kpv/voxels
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/kpv/prompts
- **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node.
- **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/kpv/voxels
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

---

# miscsubjects article bundle

> Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest.

## MASTHEAD
- **identity:** `kpv` v37 · content_hash `a90915a9fe6d5931…` · thread_head genesis · 11 DIVs
- **thesis (c1):** KPV is transported into intestinal epithelial and immune cells via the PepT1 transporter and inhibits NF-κB and MAP kinase pathways
  - c9 [human/active] 2026 comprehensive review summarizing KPV mechanisms, benefits for inflammation/gut/wound healing, safety concerns, and lack of human trials.
  - c13 [human/active] 2012 study on KPV's anti-inflammatory mechanism in bronchial epithelial cells via MC3R.
  - c16 [human/active] Wikipedia entry summarizing KPV as α-MSH fragment with anti-inflammatory properties and skincare use.
  - c31 [human/active] 2024 review discussing KPV in tissue repair and wound healing contexts.
  - c57 [human/active] 2025 review discussing peptide strategies including KPV for IBD.
  - c68 [human/active] 2025 paper on peptide strategies for retinal immunity mentioning KPV's effects in diabetic retinopathy models.
  - c69 [human/active] Review summarizing a decade of research on KPV formulation, delivery strategies like nanoparticles, and stability improvements.
- **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes
- **standing objections:** 0 open → https://miscsubjects.com/api/articles/kpv/discourse
- **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key
- **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/kpv/discourse · https://miscsubjects.com/api/protocol

## Article
- **slug:** `kpv`
- **title:** KPV: Gut-Specific Anti-Inflammatory
- **url:** https://miscsubjects.com/a/kpv
- **register:** source_ledger
- **updated:** 2026-07-17T02:39:56.879Z
- **tags:** peptide, kpv

## Body

## Overview
KPV (Lys-Pro-Val) is the C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (α-MSH).

## Mechanism
KPV is transported into intestinal epithelial and immune cells via the PepT1 transporter (mechanistic, human cell lines). It inhibits NF-κB and MAP kinase pathways, reducing pro-inflammatory cytokine secretion without broad systemic immunosuppression (mechanistic).

## Preclinical Evidence
In two murine models of colitis (DSS- and TNBS-induced), oral KPV reduced histologic inflammation, colon shortening, and pro-inflammatory cytokine expression (preclinical, mouse studies; Kannengiesser et al. 2008; Dalmasso et al. 2008).

No large-scale human clinical trials for KPV exist (absence of human data; multiple sources as of 2026). A related tripeptide K(D)PT showed signals in one phase 2 UC trial, but this is distinct.

## Repair Framing
KPV calms gut lining inflammation locally via epithelial uptake, distinct from systemic immune suppression (mechanistic/preclinical).

## Limitations
All proposed gut benefits derive from cell culture and rodent models; human safety, dosing, and efficacy data are absent.

## Claims (48 of 97 ranked)

- **c110** [mechanistic w=0.3] Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
  - who_claims: miscsubjects protocol
  - slot: limitations
- **c9** [human w=0.8] 2026 comprehensive review summarizing KPV mechanisms, benefits for inflammation/gut/wound healing, safety concerns, and lack of human trials.
  - who_claims: grok/grok-4.3
  - slot: what_is_known
  - sources: s7
- **c13** [human w=0.8] 2012 study on KPV's anti-inflammatory mechanism in bronchial epithelial cells via MC3R.
  - who_claims: grok/grok-4.3
  - slot: mechanism
  - sources: s11
- **c57** [human w=0.8] 2025 review discussing peptide strategies including KPV for IBD.
  - who_claims: grok/grok-4.3
  - slot: what_is_known
  - sources: s55
- **c7** [human w=0.65] Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.
  - who_claims: system/protocol
  - slot: disclaimer
- **c2** [preclinical w=0.5] In DSS- and TNBS-induced murine colitis models, oral KPV reduced histologic inflammation, disease activity, and cytokine expression
  - who_claims: system/unknown
  - slot: what_is_known
  - sources: s2, s3
- **c14** [preclinical w=0.5] 2016 mouse study showing KPV via PepT1 prevents colitis-associated cancer.
  - who_claims: grok/grok-4.3
  - slot: what_is_known
  - sources: s12
- **c15** [preclinical w=0.5] 2017 study on HA-functionalized nanoparticles for targeted KPV delivery in UC mouse model.
  - who_claims: grok/grok-4.3
  - slot: what_is_known
  - sources: s13
- **c79** [preclinical w=0.5] 2008 study showing KPV's anti-inflammatory effects via PepT1 transporter in intestinal cells and mouse colitis models, reducing pro-inflammatory cytokines.
  - who_claims: grok/grok-4.3
  - slot: what_is_known
  - sources: s77
- **c86** [mechanistic w=0.4] The disclaimer is a required constitution slot and does not require sourcing, as it is a standard statement on research catalogues.
  - who_claims: kimi/moonshot-v1-8k (adversary)
- **c109** [system w=0.35] KPV: Gut-Specific Anti-Inflammatory is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.
  - who_claims: miscsubjects protocol
  - slot: what_it_is
- **c8** [mechanistic w=0.3] 2017 study on transdermal delivery of KPV for potential skin inflammation treatment.
  - who_claims: grok/grok-4.3
  - slot: what_is_known
  - sources: s6
- **c10** [mechanistic w=0.3] 2026 paper on new oral delivery system for KPV and other peptides in inflammatory conditions.
  - who_claims: grok/grok-4.3
  - slot: what_is_known
  - sources: s8
- **c92** [anecdotal w=0.3] X post highlighting KPV's anti-inflammatory benefits without full alpha-MSH side effects.
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s87
- **c96** [anecdotal w=0.3] Italian X post promoting KPV for IBS, diverticula, gut inflammation, claiming superior to cortisone in animal models. (anecdotal/promotional)
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s91
- **c97** [anecdotal w=0.3] X post describing KPV as effective, well-tolerated gut anti-inflammatory in personal stack. (anecdotal, not advice)
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s92
- **c98** [anecdotal w=0.3] X user recommends KPV based on knowing multiple people helped with gut/bowel issues like Crohn's/IBS. (anecdotal)
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s93
- **c103** [anecdotal w=0.3] User mentions ongoing personal use in stack; anecdotal positive (anecdotal, not advice).
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s98
- **c16** [human w=0.8] Wikipedia entry summarizing KPV as α-MSH fragment with anti-inflammatory properties and skincare use.
  - who_claims: grok/grok-4.3
  - slot: what_is_known
  - sources: s14
- **c31** [human w=0.8] 2024 review discussing KPV in tissue repair and wound healing contexts.
  - who_claims: grok/grok-4.3
  - slot: what_is_known
  - sources: s29
- **c68** [human w=0.8] 2025 paper on peptide strategies for retinal immunity mentioning KPV's effects in diabetic retinopathy models.
  - who_claims: grok/grok-4.3
  - slot: what_is_known
  - sources: s66
- **c69** [human w=0.8] Review summarizing a decade of research on KPV formulation, delivery strategies like nanoparticles, and stability improvements.
  - who_claims: grok/grok-4.3
  - slot: what_is_known
  - sources: s67
- **c1** [preclinical w=0.22] KPV is transported into intestinal epithelial and immune cells via the PepT1 transporter and inhibits NF-κB and MAP kinase pathways
  - who_claims: system/unknown
  - slot: mechanism
  - sources: s1
- **c67** [preclinical w=0.22] 2025 review discussing anti-inflammatory peptides including KPV for IBD models, highlighting its potential in colitis.
  - who_claims: grok/grok-4.3
  - slot: what_is_known
  - sources: s65
- **c30** [mechanistic w=0.3] 2024 study on self-assembled KPV-RAPA nanoparticles for vascular calcification, showing anti-inflammatory effects.
  - who_claims: grok/grok-4.3
  - slot: what_is_known
  - sources: s28
- **c42** [mechanistic w=0.3] 2018 research on modifying KPV tripeptide for improved stability, showing parent KPV degrades quickly.
  - who_claims: grok/grok-4.3
  - slot: what_is_known
  - sources: s40
- **c80** [mechanistic w=0.3] 2024 PubMed abstract mentioning KPV tripeptide in a hydrogel for potential delivery/applications.
  - who_claims: grok/grok-4.3
  - slot: what_is_known
  - sources: s78
- **c11** [anecdotal w=0.3] Detailed user/research guide post on Reddit explaining KPV mechanisms, benefits, dosing, and research status (anecdotal/community info).
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s9
- **c12** [anecdotal w=0.3] 2025/2026 YouTube video discussing KPV benefits for inflammation and gut health with user anecdotes in comments.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s10
- **c19** [anecdotal w=0.3] User anecdotes on KPV subQ use for gut pain, dermatitis, energy; benefits reversed after stopping.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s17
- **c20** [anecdotal w=0.3] Video discussing KPV science, benefits, and risks.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s18
- **c21** [anecdotal w=0.3] User reports negative side effects from KPV including dizziness, sleep issues, headaches, brain fog, fatigue; others note it helped with MCAS inflammation or gut issues but some had to stop due to bad effects; mixed experiences with herx/die-off reactions.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s19
- **c22** [anecdotal w=0.3] Positive user experience reducing MCAS inflammation and reactions quickly with daily KPV.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s20
- **c23** [anecdotal w=0.3] User reports KPV helped gut repair after slow titration despite initial paradoxical reactions; emphasizes starting low and slow.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s21
- **c24** [anecdotal w=0.3] Positive report of KPV improving histamine tolerance, with note on possible herx reaction at start.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s22
- **c25** [anecdotal w=0.3] Strong positive experience with KPV reducing fatigue and improving food tolerance in MCAS context.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s23
- **c26** [anecdotal w=0.3] User reports dramatic ~80% symptom reduction from KPV.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s24
- **c27** [anecdotal w=0.3] Negative side effects reported: fatigue and strong apathy from low-dose KPV.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s25
- **c28** [anecdotal w=0.3] YouTube comment sharing positive outcome: KPV (with other interventions) resolved IBS, Crohn's, celiac symptoms dramatically.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s26
- **c29** [anecdotal w=0.3] Positive anecdotal report of KPV improving inflammation, skin, gut, and fungal issues like nail fungus and dandruff.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s27
- **c34** [anecdotal w=0.3] 2026 Reddit anecdotes on KPV for MCAS, mixed experiences including improvements and side effects like flushing.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s32
- **c35** [anecdotal w=0.3] Recent Reddit post summarizing KPV use for gut inflammation, dosing, side effects.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s33
- **c38** [anecdotal w=0.3] User guide on Reddit explaining KPV mechanism for gut and inflammation.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s36
- **c39** [anecdotal w=0.3] YouTube video discussing KPV science, benefits for gut/skin/inflammation with anecdotal mentions.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s37
- **c43** [anecdotal w=0.3] MCAS subreddit users discussing personal experiences with KPV for symptoms like fatigue and inflammation.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s41
- **c44** [anecdotal w=0.3] User anecdote on KPV for long COVID gut issues and MCAS reversal.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s42
- **c45** [anecdotal w=0.3] Anecdotal report of negative side effects from KPV in MCAS patient.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s43
- **c48** [anecdotal w=0.3] Multiple users report initial fatigue, flu-like/cold symptoms, dizziness, joint stiffening/herx reactions, low BP, bloating, back pain from KPV (often high starting doses like 250-500mcg subq); some note stomach/reflux improvement but stopped due to side effects; others suggest starting at 50mcg and possible herx or healing flare.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s46

## Voxel graph (97 atoms · 206 edges)
- full graph: https://miscsubjects.com/api/articles/kpv/voxels

## Article constitution

- full: https://miscsubjects.com/api/articles/constitution

## Source ledger (40 of 103)
- chain valid: yes · head: `3490badc045cdf94`

### s1 · pubmed · ok
- title: PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation
- url: https://pubmed.ncbi.nlm.nih.gov/18061177/
- summary: Human cell line and mouse colitis study on PepT1-mediated uptake and NF-kB inhibition
- quote: KPV acts via PepT1 expressed in immune and intestinal epithelial cells... Nanomolar concentrations of KPV inhibit the activation of NF-κB and MAP kinase inflammatory signaling pathways
- claim_ids: c1
- hash: `eb658c416c371845`

### s2 · pubmed · ok
- title: Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease
- url: https://pubmed.ncbi.nlm.nih.gov/18092346/
- summary: Mouse colitis model results
- quote: The melanocortin-derived tripeptide KPV showed significant anti-inflammatory effects in 2 murine models of colitis
- claim_ids: c2
- hash: `9e0f87fa6cc74caa`

### s3 · pubmed · ok
- title: PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation
- url: https://pubmed.ncbi.nlm.nih.gov/18061177/
- summary: Confirms mouse model efficacy
- quote: oral administration of KPV reduces the incidence of DSS- and TNBS-induced colitis
- claim_ids: c2
- hash: `a61cc5b5631aaad7`

### s4 · other · ok
- title: KPV: The Anti-Inflammatory Tripeptide for Gut and Skin
- url: https://meto.co/blog/kpv-peptide-anti-inflammatory-gut
- summary: Confirms absence of human trials
- quote: No human clinical trials exist yet... As of 2026, no registered Phase I or Phase II trials for KPV in humans are listed on ClinicalTrials.gov
- claim_ids: c3, c84
- hash: `74ae3566df0b9a01`

### s5 · other · ok
- title: KPV Research & Evidence
- url: https://peptidetreatments.com/peptides/kpv/research
- summary: Reinforces no human data
- quote: KPV has zero human clinical trials. All proposed benefits for IBD, gut health... are extrapolated from cell culture and mouse studies
- claim_ids: c3, c84
- hash: `60a1a146d6450d37`

### s6 · pubmed · ok
- title: Transdermal Iontophoretic Delivery of Lysine-Proline-Valine (KPV) Peptide Across Microporated Human Skin
- url: https://pubmed.ncbi.nlm.nih.gov/28343991/
- summary: 2017 study on transdermal delivery of KPV for potential skin inflammation treatment.
- quote: Lysine-proline-valine (KPV) is a C-terminal peptide fragment of α-melanocyte stimulating hormone with potent anti-inflammatory properties.
- claim_ids: c8
- hash: `c629aef257267c2d`

### s7 · review · ok
- title: KPV Peptide | Benefits, Safety & Buying Advice [2026]
- url: https://www.innerbody.com/kpv-peptide
- summary: 2026 comprehensive review summarizing KPV mechanisms, benefits for inflammation/gut/wound healing, safety concerns, and lack of human trials.
- quote: Of note, the research on KPV’s effects has been done primarily in animal models and human cell cultures, not in human subjects directly. Therefore, the support for its therapeutic uses is limited, albeit largely optimistic.
- claim_ids: c9
- hash: `b4d7eba729eea71d`

### s8 · review · ok
- title: Inflammation-triggered self-immolative conjugates enable oral delivery of anti-inflammatory peptides
- url: https://pmc.ncbi.nlm.nih.gov/articles/PMC12802832/
- summary: 2026 paper on new oral delivery system for KPV and other peptides in inflammatory conditions.
- quote: Using three anti-inflammatory peptides (KPV, Ac-QAW, and IRW), we demonstrated that the engineered conjugates exhibit remarkable GI stability
- claim_ids: c10
- hash: `6d62216c3523e827`

### s9 · reddit · ok
- title: A Complete Guide for KPV
- url: https://www.reddit.com/r/Ameano_Peptides/comments/1o7vx9t/a_complete_guide_for_kpv/
- summary: Detailed user/research guide post on Reddit explaining KPV mechanisms, benefits, dosing, and research status (anecdotal/community info).
- quote: KPV (Lysine-Proline-Valine) is a small tripeptide derived from the C-terminal sequence of α-MSH (alpha-melanocyte stimulating hormone). It is known for its potent anti-inflammatory, immunomodulatory, and mucosal healing actions, particularly in gastrointestinal and epithelial tissues.
- claim_ids: c11, c3
- hash: `8350296af4fa168c`

### s10 · youtube · http_429
- title: The Best Peptide for Inflammation, Gut Health, and Visceral Fat Loss (KPV Peptide)
- url: https://www.youtube.com/watch?v=wdCjXXmRoEw
- summary: 2025/2026 YouTube video discussing KPV benefits for inflammation and gut health with user anecdotes in comments.
- quote: KPV is a 3-amino-acid peptide (Lysine-Proline-Valine) that fights inflammation where it starts—inside your cells.
- claim_ids: c12, c3
- hash: `a33483841d80f954`

### s11 · pubmed · ok
- title: Inhibition of cellular and systemic inflammation cues in human bronchial epithelial cells by melanocortin-related peptides: mechanism of KPV action and a role for MC3R agonists
- url: https://pubmed.ncbi.nlm.nih.gov/22837805/
- summary: 2012 study on KPV's anti-inflammatory mechanism in bronchial epithelial cells via MC3R.
- quote: This study investigates the mechanism by which the α-melanocyte stimulating hormone-derived tripeptide, KPV, and the agonist of the dominant melanocortin receptor in airway epithelium (MC3R), γ-melanocyte stimulating hormone (γ-MSH), suppress inflammation in immortalised human bronchial airway epithelium.
- claim_ids: c13
- hash: `98761ae7e1ae7073`

### s12 · pubmed · ok
- title: Critical role of PepT1 in promoting colitis-associated cancer and therapeutic benefits of the anti-inflammatory PepT1-mediated tripeptide KPV in a murine model
- url: https://pubmed.ncbi.nlm.nih.gov/27458604/
- summary: 2016 mouse study showing KPV via PepT1 prevents colitis-associated cancer.
- quote: The use of an anti-inflammatory tripeptide KPV (Lys-Pro-Val) transported by PepT1 was able to prevent carcinogenesis in WT mice.
- claim_ids: c14
- hash: `7a8847b7f8a3b349`

### s13 · pubmed · ok
- title: Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis
- url: https://pubmed.ncbi.nlm.nih.gov/28143741/
- summary: 2017 study on HA-functionalized nanoparticles for targeted KPV delivery in UC mouse model.
- quote: We found that HA-KPV-NPs exert combined effects against UC by both accelerating mucosal healing and alleviating inflammation.
- claim_ids: c15
- hash: `4f9fa03739dfded0`

### s14 · review · ok
- title: KPV tripeptide
- url: https://en.wikipedia.org/wiki/KPV_tripeptide
- summary: Wikipedia entry summarizing KPV as α-MSH fragment with anti-inflammatory properties and skincare use.
- quote: KPV tripeptide (Lys-Pro-Val) is a tripeptide derivative that is derived from the C-terminal fragment of alpha-MSH. It has antiinflammatory effects, and is used in skincare products, as well as having been researched for other potential medical applications.
- claim_ids: c16
- hash: `dafafa3f157cd41b`

### s15 · medical · http_403
- title: KPV Peptide: Benefits, Dosage & 2026 Legal Status
- url: https://riteaid.com/peptides/kpv
- summary: 2026 article on KPV benefits, dosage, and updated FDA compounding legal status.
- quote: It is one of the twelve peptides the FDA removed from the list that restricted compounding in April 2026, and one of seven under formal advisory review on July 23–24, 2026.
- claim_ids: c17
- hash: `bf8e2b14f2d0910f`

### s16 · medical · ok
- title: KPV Peptide: Comprehensive Guide to Benefits, Dosage and ...
- url: https://www.helimeds.com/blog/kpv-peptide
- summary: 2026 guide covering KPV chemistry, uses, and 2026 FDA review details.
- quote: The FDAs Pharmacy Compounding Advisory Committee (PCAC) will review seven peptides to potentially allow compounders to produce them.
- claim_ids: c18
- hash: `10980839b7cefef3`

### s17 · reddit · ok
- title: Anyone here with experience using KPV or other peptides ...
- url: https://www.reddit.com/r/Biohackers/comments/1q83047/anyone_here_with_experience_using_kpv_or_other/
- summary: User anecdotes on KPV subQ use for gut pain, dermatitis, energy; benefits reversed after stopping.
- quote: I personally tried KPV subcutaneously. 200µg for 12 days (one 5mg vial). ... Significant improvements on the Bistrol scale. I no longer suffered from nighttime duodenal pain. My seborrheic dermatitis is greatly improving. More energy. No side effects.
- claim_ids: c19
- hash: `2b7b3fd6ea51fa66`

### s18 · youtube · http_429
- title: KPV Peptide - Miracle Cure or Major Risk?
- url: https://www.youtube.com/watch?v=5ph3S8mVuuE
- summary: Video discussing KPV science, benefits, and risks.
- quote: Discover the science behind KPV peptide, a powerful tripeptide known for its anti-inflammatory and immune-balancing properties.
- claim_ids: c20
- hash: `2a2f3b4466d1be1a`

### s19 · reddit · ok
- title: KPV Peptide Side Effects
- url: https://www.reddit.com/r/Longcovidgutdysbiosis/comments/1je6riv/kpv_peptide_side_effects/
- summary: User reports negative side effects from KPV including dizziness, sleep issues, headaches, brain fog, fatigue; others note it helped with MCAS inflammation or gut issues but some had to stop due to bad effects; mixed experiences with herx/die-off reactions.
- quote: Kpv & BPC157 both made me feel dizzy, impaired my sleep, gave me headaches and brain fog, and caused fatigue. It sucked bc I actually noticed ...
- claim_ids: c21
- hash: `badfcc90cf4ace5a`

### s20 · reddit · ok
- title: KPV Peptide Side Effects
- url: https://www.reddit.com/r/Longcovidgutdysbiosis/comments/1je6riv/kpv_peptide_side_effects/
- summary: Positive user experience reducing MCAS inflammation and reactions quickly with daily KPV.
- quote: Kvp simmers down the inflammation in MCAS.. almost instantly. 40 days in. 500 MCG daily. ... What I’ve noticed is since taking some peptides it’s taken the edge off and reduce the intensity of the instant reaction. Even that I’m deeply grateful for.
- claim_ids: c22
- hash: `81904e5e8e060700`

### s21 · reddit · ok
- title: KPV peptides
- url: https://www.reddit.com/r/Longcovidgutdysbiosis/comments/1iikbxd/kpv_peptides/
- summary: User reports KPV helped gut repair after slow titration despite initial paradoxical reactions; emphasizes starting low and slow.
- quote: It definitely helped with gut repair but it took me a long time to titrate up my dose. It did cause paradoxical reactions early on. After months, I'm just now at 1 capsule every other day.
- claim_ids: c23
- hash: `44ffe3f087177783`

### s22 · reddit · ok
- title: KPV peptides
- url: https://www.reddit.com/r/Longcovidgutdysbiosis/comments/1iikbxd/kpv_peptides/
- summary: Positive report of KPV improving histamine tolerance, with note on possible herx reaction at start.
- quote: Start at a very low dose, you might herx. This has helped me a lot with my histamine tolerance.
- claim_ids: c24
- hash: `347d8111ad213ca6`

### s23 · reddit · ok
- title: Is anyone being helped by peptides?
- url: https://www.reddit.com/r/MCAS/comments/1rpepqr/is_anyone_being_helped_by_peptides/
- summary: Strong positive experience with KPV reducing fatigue and improving food tolerance in MCAS context.
- quote: KPV & GHK-Cu (injections) have helped me immensely, both in terms of fatigue and in terms of food tolerance and related symptoms.
- claim_ids: c25
- hash: `505f6decbbbfaacf`

### s24 · reddit · ok
- title: Is anyone being helped by peptides?
- url: https://www.reddit.com/r/MCAS/comments/1rpepqr/is_anyone_being_helped_by_peptides/
- summary: User reports dramatic ~80% symptom reduction from KPV.
- quote: KPV has helped me dramatically. About 80% reduction in symptoms.
- claim_ids: c26
- hash: `03c572f9b6c8acb8`

### s25 · reddit · ok
- title: KPV fatigue and apathy
- url: https://www.reddit.com/r/Biohackers/comments/1ribbuz/kpv_fatigue_and_apathy/
- summary: Negative side effects reported: fatigue and strong apathy from low-dose KPV.
- quote: Been on 200mcg of KPV for a few days and am a little fatigue but the apathy seems a bit strong.
- claim_ids: c27
- hash: `216fd11f233e48d3`

### s26 · youtube · http_429
- title: This Peptide “Fixes” Your Gut... But There's a Catch
- url: https://www.youtube.com/watch?v=spOpffLj9Oo
- summary: YouTube comment sharing positive outcome: KPV (with other interventions) resolved IBS, Crohn's, celiac symptoms dramatically.
- quote: I have IBS, Crohn's and celiac. Carnivore, KPV and R e t a had helped me so much . I have my life back.
- claim_ids: c28
- hash: `8a7a4558259eda90`

### s27 · reddit · ok
- title: How effective is KPV peptide? Is it really worth it?
- url: https://www.reddit.com/r/Biohackers/comments/1s69j21/how_effective_is_kpv_peptide_is_it_really_worth_it/
- summary: Positive anecdotal report of KPV improving inflammation, skin, gut, and fungal issues like nail fungus and dandruff.
- quote: Great for overall inflammation, skin inflammation and gut health , fungus , etc. My toe nail never gets yellow anymore, dandruff completely gone ...
- claim_ids: c29
- hash: `cbc6885c1802a062`

### s28 · pubmed · ok
- title: KPV and RAPA Self-Assembled into Carrier-Free Nanodrugs for Vascular Calcification Therapy
- url: https://pubmed.ncbi.nlm.nih.gov/39252648/
- summary: 2024 study on self-assembled KPV-RAPA nanoparticles for vascular calcification, showing anti-inflammatory effects.
- quote: Herein, an anti-inflammatory peptide (lysine-proline-valine peptides , KPV ) and the autophagy activator rapamycin (RAPA) are self-assembled to form new carrier-free spherical nanoparticles (NPs), which shows good stability and biosafety.
- claim_ids: c30
- hash: `90076a9cef0776f4`

### s29 · review · ok
- title: Bioactive peptides and proteins for tissue repair
- url: https://pmc.ncbi.nlm.nih.gov/articles/PMC11619216/
- summary: 2024 review discussing KPV in tissue repair and wound healing contexts.
- quote: The KPV peptide from the bottom layer was rapidly released within 1 − 3 d to exert an anti-inflammatory effect during the early stages of wound healing, while ...
- claim_ids: c31
- hash: `4a659e8395711061`

### s30 · medical · ok
- title: Is KPV Peptide Safe To Take?
- url: https://formationmed.com/is-kpv-peptide-safe-to-take/
- summary: 2026 medical overview on KPV safety, benefits for inflammation, gut, skin; emphasizes supervision.
- quote: KPV peptide can be safe to take when it is prescribed by a licensed medical provider and sourced from a licensed compounding pharmacy that ...
- claim_ids: c32
- hash: `a7a3d4fda1d07b82`

### s31 · medical · ok
- title: KPV Peptide: Anti-Inflammatory Mechanisms and Research
- url: https://newtropin.com/peptides/kpv
- summary: 2026 clinical overview of KPV mechanisms, origin from alpha-MSH, limited human data.
- quote: Research has identified receptor expression in intestinal, dermal, and central nervous system tissues, though the pharmacokinetic profile of KPV in humans remains to be fully characterized through clinical trials.
- claim_ids: c3
- hash: `959448730a5efcc2`

### s32 · reddit · ok
- title: Best peptides and brands for MCAS ? BPC-157, KPV and ...
- url: https://www.reddit.com/r/MCAS/comments/1lki5p2/best_peptides_and_brands_for_mcas_bpc157_kpv_and/
- summary: 2026 Reddit anecdotes on KPV for MCAS, mixed experiences including improvements and side effects like flushing.
- quote: I have been using KPV Ultra and BPC-157 since April and no longer need to eat a low histamine diet.
- claim_ids: c34
- hash: `610a84254a3a81e9`

### s33 · reddit · ok
- title: KPV Explained Simply (The Gut Inflammation Fighter)
- url: https://www.reddit.com/r/PeptideProgress/comments/1u17ht6/kpv_explained_simply_the_gut_inflammation_fighter/
- summary: Recent Reddit post summarizing KPV use for gut inflammation, dosing, side effects.
- quote: KPV is a specialized peptide for a specific problem: inflammation. If you have a clear inflammatory issue, especially gut or skin related ...
- claim_ids: c35
- hash: `7e796b2d7b7540da`

### s34 · other · ok
- title: What is KPV and why is it being studied?
- url: https://www.instagram.com/reel/DYfvjzVDjSD/
- summary: 2026 Instagram reel on KPV benefits for gut and inflammation.
- quote: Benefits of KPV peptide therapy may include: • Support for gut barrier integrity • Reduced gastrointestinal inflammation • Improved digestive ...
- claim_ids: c3
- hash: `154044478c4a236d`

### s35 · review · ok
- title: Anti‐Inflammatory Peptides as Promising Therapeutics for Inflammatory Bowel Disease
- url: https://onlinelibrary.wiley.com/doi/full/10.1002/jgh3.70212
- summary: 2025 review discussing KPV/K(D)PT in IBD, including references to clinical trials and anti-inflammatory potential.
- quote: The study conducted by Kucharzik and colleagues was a phase 2 clinical trial designed to investigate the efficacy of K(D)PT medication in UC cases.
- claim_ids: c3
- hash: `956cffc62c4d47fa`

### s36 · reddit · ok
- title: KPV peptide guide
- url: https://www.reddit.com/r/NTNPerformance/comments/1talx2b/kpv_peptide_guide/
- summary: User guide on Reddit explaining KPV mechanism for gut and inflammation.
- quote: KPV is a naturally occurring tripeptide. Three amino acids. Lysine, proline, valine. It's the C-terminal fragment of alpha-MSH which is a hormone your body already produces
- claim_ids: c38
- hash: `a492a7658f6b03e3`

### s37 · youtube · http_429
- title: KPV: The Barrier Repair Peptide (Gut, Skin & Chronic Inflammation)
- url: https://www.youtube.com/watch?v=XE0k4AW0uag
- summary: YouTube video discussing KPV science, benefits for gut/skin/inflammation with anecdotal mentions.
- quote: KPV is one of the smallest peptides studied in inflammation biology — but it may be one of the most important when it comes to gut health, skin barrier repair, immune balance, and chronic inflammation, especially in midlife.
- claim_ids: c39
- hash: `026d2f039b3e7caf`

### s38 · medical · ok
- title: KPV: The Anti-Inflammatory Peptide Under FDA Review
- url: https://healingmaps.com/kpv-peptide-anti-inflammatory-wound-healing/
- summary: Article on KPV regulatory status in 2026 and preclinical evidence for inflammation/wound healing.
- quote: Regulatory Update (April 2026): KPV is one of seven peptides scheduled for FDA Pharmacy Compounding Advisory Committee review on July 23, 2026.
- claim_ids: c3
- hash: `311e4958f51006b5`

### s39 · medical · ok
- title: KPV — Molecular Specifications & Research Monograph
- url: https://peptidebiologix.com/kpv
- summary: Monograph summarizing research, including pilot clinical trial data on KPV for UC.
- quote: The most significant clinical data comes from studies in inflammatory bowel disease patients. A pilot clinical trial investigated topical (intrarectal) administration of KPV in patients with mild to moderate ulcerative colitis.
- claim_ids: c3
- hash: `3f4baf027396e7ce`

### s40 · pubmed · ok
- title: Structural modification of the tripeptide KPV by reductive amination
- url: https://pmc.ncbi.nlm.nih.gov/articles/PMC6023233/
- summary: 2018 research on modifying KPV tripeptide for improved stability, showing parent KPV degrades quickly.
- quote: The “parent” peptide , Ac- KPV -NH2 (12c) was degraded to its three constituent amino acids within 24 hours.
- claim_ids: c42
- hash: `a63b0be083288912`

## Provenance (37 model passes)
- chain valid: yes · head: `58d57c68b8fe4cde`

- sources · grok-4.3 · 2026-06-29T15:37 · hash `faa962b56fd6`
- sources · grok-4.3 · 2026-06-29T17:40 · hash `27ad9edd4063`
- sources · grok-4.3 · 2026-06-29T17:40 · hash `814151138857`
- sources · grok-4.3 · 2026-06-29T17:41 · hash `af07dfffdc2b`
- repair · repair · 2026-06-29T19:28 · hash `6eba82a4d4bc`
- claim · fill-slots · 2026-06-29T20:42 · hash `f7d1badc7528`
- claim · fill-slots · 2026-06-29T20:42 · hash `e56cd3862f16`
- voxel_divide · owner · 2026-07-17T02:39 · hash `58d57c68b8fe`

## Question graph
- questions: 0 · evidence ingests: 1

## LLM manifest — how to communicate with this ledger

- system map: https://miscsubjects.com/api/articles/system-map?format=markdown
- topology (ranked): https://miscsubjects.com/api/articles/kpv/topology
- ingest: POST https://miscsubjects.com/api/protocol/ingest
- claim: POST https://miscsubjects.com/api/protocol/claim

### Quick actions for this article
- **Read live:** https://miscsubjects.com/api/articles/kpv/topology
- **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"kpv","question":"..."}`
- **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest kpv|your evidence`
- **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim kpv|tier|assertion`
- **iMessage ask:** `kpv|your question`
- **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown


---

## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `system_map` — **System map**
Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **article slug:** `kpv`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **read:** https://miscsubjects.com/api/articles/system-map

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/kpv/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest
- **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip
- **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/kpv/bundle?format=markdown
- **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*